Cardinal Health Reports Strong Q2 Earnings

Prescription drug distributor exceeds Wall Street expectations

Published on Feb. 5, 2026

Cardinal Health Inc. reported fiscal second-quarter earnings of $467 million, or $1.97 per share. Adjusted earnings came in at $2.63 per share, beating the average analyst estimate of $2.39 per share. The company also posted revenue of $65.63 billion, exceeding Street forecasts. Cardinal expects full-year earnings in the range of $10.15 to $10.35 per share.

Why it matters

Cardinal Health's strong quarterly performance demonstrates the company's ability to navigate the challenges facing the healthcare industry, including supply chain disruptions and pricing pressures. As a major distributor of pharmaceutical products, Cardinal's results provide insight into the overall health of the sector.

The details

Cardinal Health reported adjusted earnings of $2.63 per share, topping the $2.39 per share expected by analysts surveyed by Zacks Investment Research. Revenue came in at $65.63 billion, higher than the $65.04 billion forecast. The company attributed its solid results to effective cost management and strong demand for its products and services.

  • Cardinal Health reported its fiscal second-quarter earnings on February 5, 2026.

The players

Cardinal Health Inc.

A major prescription drug distributor based in Dublin, Ohio.

Got photos? Submit your photos here. ›

The takeaway

Cardinal Health's strong quarterly performance underscores the company's ability to navigate the challenges facing the healthcare industry, positioning it well for continued growth and success.